Website & contact details
- Website
Mirzyme Therapeutics Limited
- Incorporated
- 19 April 2016 (10 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Syed Sami Ahmad
- Owned by
- Asif Syed Ahmed
- Accounts type
- Total exemption full
- Region
- West Midlands
- Address
- Faraday WharfInnovation Birmingham CampusHolt StreetBirminghamB7 4BB
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 2 May 2027
- Last conf. stmt
- 18 April 2026
Officers 4 active
Officer details are public data from the Companies House register.
Ahmad, Syed Sami
Director · Appointed 11 September 2023
American
Born August 1961 (65)
Director · Appointed 11 September 2023
British
Born September 1963 (63)
Director · Appointed 3 October 2018
British
Born March 1962 (64)
Director · Appointed 19 April 2016
British
Born June 1960 (66)
Officer history (1 former)
11 September 2023
Appointed Ahmad, Syed Sami as Director
11 September 2023
1 June 2021
Resigned Hayat, Syed Omar as Director
3 October 2018
1 September 2018
Appointed Hayat, Syed Omar as Director
19 April 2016
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Asif Syed Ahmed
Individual · Notified 19 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
British
Born June 1960 (66)
Financials
Figures from 2024 accounts. Newer accounts, made up to 31 December 2025, are filed but not read yet. See them on Companies House
- Cash
- £314,076
- Current Ratio
- 2.5x
Trend
Shareholder Funds
Balance sheet detail
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £471,759 | £372,442 | £301,726 | £267,478 | £211,407 | |
| Current Assets | £371,547 | £770,148 | £884,807 | £1,082,232 | £1,177,785 | £1,216,012 |
| Debtors | £57,471 | £21,419 | £5,534 | £3,171 | £4,558 | £9,034 |
| Cash | £314,076 | £748,729 | £879,273 | £1,079,061 | £1,173,227 | £1,206,978 |
| Creditors (< 1 year) | £147,238 | £226,200 | £89,221 | £68,126 | £62,134 | £12,205 |
| Net Current Assets | £224,309 | £543,948 | £795,586 | £1,014,106 | £1,115,651 | £1,203,807 |
| Shareholder Funds | £696,068 | £914,118 | £1,168,028 | £1,315,832 | £1,383,129 | £1,415,214 |
What Mirzyme Therapeutics say about themselves
“MirZyme Therapeutics is an innovative biopharmaceutical company that focuses on the ......”
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 25 August 2026 | Total exemption full accounts | 31 December 2025 | ||
| 1 May 2026 | Confirmation statement with no updates | 18 April 2026 | ||
| 30 September 2025 | Total exemption full accounts | 31 December 2024 | ||
| 9 July 2025 | Compulsory strike-off action has been discontinued | |||
| 8 July 2025 | First Gazette notice for compulsory strike-off |
Other companies in this industry
Sandwich
Newcastle Upon Tyne
Edinburgh
Edinburgh
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →